Gubra is well-known as a professional and strong scientific collaboration partner. Our agile data-driven approach is highly valued by our partners and is key to our success. We dedicate great attention and resources to each partnership, and we are always open for new collaboration opportunities.
Why choose Gubra?
- Trusted collaboration partner
- Extensive scientific knowledge
- One-team approach to partnerships
- Professional & agile project organization
- High quality & rapid data delivery
Consult with Lise Biehl Rudkjær
Senior Director, Business Development
Choose the right, trustworthy discovery partner.
Our Areas of Expertise
Disease Focus Areas
- Metabolism, fibrosis and inflammation
- NASH, obesity, renal and cardiovascular diseases
- Inflammatory Bowel Disease (IBD)
- Idiopathic pulmonary fibrosis (IPF)
Peptide Drug Discovery
All types of peptide molecules
Rapid peptide synthesis – up to 4000 peptides/month
- Unbiased and systematic approach through streaMLine platform
- Peptide hit to develop into a clinical candidate
All types of targets
Advanced data-driven approach through PreDict platform
Rapid In Vivo validation and Proof of Concept
Flexible inter-organ approach
How we work
We collaborate with pharmaceutical and biotech companies and leading academic institutions. We are a trusted, competent partner in the discovery and preclinical space, and early clinical development.
One-team or joint efforts
We can work with your scientists as one team, or you can guide us as an external independent biotech group. You can choose what is best suited for your project.
Flexible approach to deal making
We recognize that every partner and program is unique and we take a pragmatic approach to deal making. The goal is to provide benefits for all parties with creative solutions.
For further information
Hørsholm Kongevej 11B
+45 3152 2650